Literature DB >> 19101731

Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI.

Akihiko Matsumine1, K Kusuzaki, T Nakamura, S Nakazora, R Niimi, T Matsubara, K Uchida, T Murata, I Kudawara, T Ueda, N Naka, N Araki, M Maeda, A Uchida.   

Abstract

PURPOSE: The imaging discrimination between neurofibroma (NF) and malignant peripheral nerve sheath tumor (MPNST) is clinically very important. The purpose of this study is to define the criteria for the differential diagnosis between NF and MPNST on MRI in neurofibromatosis 1 (NF1).
METHODS: A total of 37 patients with NF1, 18 NFs and 19 MPNSTs were evaluated by MRI at 1.5 T. Magnetic resonance imaging (MRI) findings were compared using univariate and multivariate analyses.
RESULTS: The MRI findings characteristic of MPNST (p < 0.05) were an irregular tumor shape (15/19 in MPNST vs. 5/18 in NF), unclear margin (13/19 in MPNST vs. 6/18 in NF), intra-tumoral lobulation (12/19 in MPNST vs. 3/18 in NF), presence of high signal-intensity area on T1-weighted images (T1WI) (12/19 in MPNST vs. 1/18 in NF), no target sign (0/19 in MPNST vs. 12/18 in NF), inhomogeneous enhancement on contract-enhanced T1WI (17/18 in MPNST vs. 9/16 in NF) and a lower rate of enhanced area (54% in MPNST vs. 87% in NF) were critical indicators to differentiate MPNST from NF. A multivariate analysis showed that intra-tumoral lobulation and the presence of a high signal-intensity area on T1WI were considered to be diagnostic indicators of MPNST. The sensitivity and specificity for these two items were 63.2, 83.3, 63.2 and 87.5%, respectively.
CONCLUSION: MRI shows features which were helpful for differentiating MPNST from NF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19101731     DOI: 10.1007/s00432-008-0523-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  26 in total

Review 1.  Neurofibromatosis type 1: a diagnostic mimicker at CT.

Authors:  B J Fortman; B S Kuszyk; B A Urban; E K Fishman
Journal:  Radiographics       Date:  2001 May-Jun       Impact factor: 5.333

2.  Positron emission tomography in the detection and management of sarcomatous transformation in neurofibromatosis.

Authors:  S B Solomon; A Semih Dogan; T L Nicol; J N Campbell; M G Pomper
Journal:  Clin Nucl Med       Date:  2001-06       Impact factor: 7.794

3.  Malignant peripheral nerve sheath tumours associated with von Recklinghausen's neurofibromatosis.

Authors:  R C Ramanathan; J M Thomas
Journal:  Eur J Surg Oncol       Date:  1999-04       Impact factor: 4.424

4.  MR imaging of soft-tissue masses: role of gadopentetate dimeglumine.

Authors:  R A Benedikt; J S Jelinek; M J Kransdorf; R P Moser; B H Berrey
Journal:  J Magn Reson Imaging       Date:  1994 May-Jun       Impact factor: 4.813

5.  CT of sarcomatous degeneration in neurofibromatosis.

Authors:  B G Coleman; P H Arger; M K Dalinka; A C Obringer; B R Raney; A T Meadows
Journal:  AJR Am J Roentgenol       Date:  1983-02       Impact factor: 3.959

6.  Intrathoracic neurogenic tumors: MR-pathologic correlation.

Authors:  F Sakai; S Sone; K Kiyono; A Maruyama; H Ueda; J Aoki; T Kawai; K Ishii; M Morimoto; M Haniuda
Journal:  AJR Am J Roentgenol       Date:  1992-08       Impact factor: 3.959

7.  Malignant peripheral nerve sheath tumors in neurofibromatosis 1.

Authors:  A A King; M R Debaun; V M Riccardi; D H Gutmann
Journal:  Am J Med Genet       Date:  2000-08-28

8.  Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization?

Authors:  H J van der Woude; K L Verstraete; P C Hogendoorn; A H Taminiau; J Hermans; J L Bloem
Journal:  Radiology       Date:  1998-09       Impact factor: 11.105

9.  Extraaxial neurofibromas versus neurilemmomas: discrimination with MRI.

Authors:  Won-Hee Jee; Soon-Nam Oh; Thomas McCauley; Kyung-Nam Ryu; Jin-Suck Suh; Jeong-Hoon Lee; Jung-Mi Park; Kyung-Ah Chun; Mi-Sook Sung; Kijun Kim; Yeon-Soo Lee; Yong-Koo Kang; In-Young Ok; Jung-Man Kim
Journal:  AJR Am J Roentgenol       Date:  2004-09       Impact factor: 3.959

10.  Soft-tissue masses: diagnosis using MR imaging.

Authors:  M J Kransdorf; J S Jelinek; R P Moser; J A Utz; A C Brower; T M Hudson; B H Berrey
Journal:  AJR Am J Roentgenol       Date:  1989-09       Impact factor: 3.959

View more
  25 in total

1.  [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation.

Authors:  L L Tsai; L Drubach; F Fahey; M Irons; S Voss; N J Ullrich
Journal:  J Neurooncol       Date:  2012-03-11       Impact factor: 4.130

Review 2.  Neuroimaging of phakomatoses: overview and advances.

Authors:  Gilbert Vézina
Journal:  Pediatr Radiol       Date:  2015-09-07

3.  Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.

Authors:  J Uthoff; F A De Stefano; K Panzer; B W Darbro; T S Sato; R Khanna; D E Quelle; D K Meyerholz; J Weimer; J C Sieren
Journal:  J Neuroradiol       Date:  2018-06-27       Impact factor: 3.447

4.  Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI.

Authors:  Christian Philipp Reinert; Martin Ulrich Schuhmann; Benjamin Bender; Isabel Gugel; Christian la Fougère; Jürgen Schäfer; Sergios Gatidis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-12-08       Impact factor: 9.236

5.  Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging.

Authors:  Lennart Well; Johannes Salamon; Michael G Kaul; Said Farschtschi; Jochen Herrmann; Karin I Geier; Christian Hagel; Maximilian Bockhorn; Peter Bannas; Gerhard Adam; Victor F Mautner; Thorsten Derlin
Journal:  Neuro Oncol       Date:  2019-03-18       Impact factor: 12.300

6.  Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1.

Authors:  Johannes Salamon; Thorsten Derlin; Peter Bannas; Jasmin D Busch; Jochen Herrmann; Maximilian Bockhorn; Christian Hagel; Reinhard E Friedrich; Gerhard Adam; Victor F Mautner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-12       Impact factor: 9.236

7.  Characterization of peripheral nerve sheath tumors with 3T proton MR spectroscopy.

Authors:  L M Fayad; X Wang; J O Blakeley; D J Durand; M A Jacobs; S Demehri; T K Subhawong; T Soldatos; P B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-28       Impact factor: 3.825

8.  18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off.

Authors:  Johannes Salamon; Simon Veldhoen; Ivayla Apostolova; Peter Bannas; Jin Yamamura; Jochen Herrmann; Reinhard E Friedrich; Gerhard Adam; Victor F Mautner; Thorsten Derlin
Journal:  Eur Radiol       Date:  2013-10-05       Impact factor: 5.315

9.  Primary retroperitoneal malignant melanoma: A case report.

Authors:  Guo-Bing Liu; Guang-Yao Wu; Prasanna Ghimire; Zai-Peng Zhang
Journal:  Oncol Lett       Date:  2011-08-29       Impact factor: 2.967

Review 10.  What MRI can tell us about neurogenic tumors and rhabdomyosarcoma.

Authors:  M Beth McCarville
Journal:  Pediatr Radiol       Date:  2016-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.